BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6816179)

  • 1. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
    Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
    Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
    Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
    Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodynamic effects and effects on plasma renin activity of injectable acebutolol in arterial hypertension].
    Lekieffre J; Carré A; Ginestet A; Dewailly P; Warembourg H
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3247-51. PubMed ID: 768906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
    Luchsinger A; Grilli M; Forte P; Morales E; Velasco M
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Excessive prolactinemic response to sulpiride in patients with mild essential hypertension. Index of diminished hypothalamic dopaminergic activity].
    Paladini G; Sponza E; Geatti O; Di Chiara F; Bertolutti T
    Minerva Med; 1980 Sep; 71(31):2229-35. PubMed ID: 6999383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension.
    v d Meiracker A; Man in't Veld AJ; van Eck HR; Wenting GJ; Schalekamp MA
    J Hypertens Suppl; 1984 Dec; 2(3):S581-3. PubMed ID: 6100755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of guanfacine in essential hypertension.
    Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
    Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Features of dopaminergic system function in menopausal females with arterial hypertension].
    Ustinova SE; Iarnykh EV; Masenko VP; Arabidze GG
    Ter Arkh; 2000; 72(1):35-40. PubMed ID: 10687204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
    Allal J; Pornin M; Rossi F; Poupet JY; Bordage JP; Barraine R
    Arch Mal Coeur Vaiss; 1984 Apr; 77(4):458-67. PubMed ID: 6426432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
    Jungmann E; Haak T; Althoff PH; Fassbinder W; Schöffling K
    Arzneimittelforschung; 1988 Feb; 38(2):296-300. PubMed ID: 3285838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic and dopaminergic regulation of circulating beta-endorphin-like immunoreactivity in hypertension.
    Alföldi A; Simkó K; Fekete MI; Farsang C
    Acta Physiol Hung; 1991; 78(1):99-106. PubMed ID: 1763654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional relationships between plasma renin activity and hemodynamic indices in essential arterial hypertension].
    Maugeri Saccà C; Zoccali C; Cerrai T; Mallamaci F; Delfino D; De Vito M
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2446-52. PubMed ID: 7008811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic changes under metoprolol compared to propranolol in hypertensive patients].
    Pfisterer M; Burkart F; Bühler FR; Schweizer W
    Schweiz Med Wochenschr; 1976 Nov; 106(45):1567-9. PubMed ID: 1013675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Domperidone on the Bromocriptine-Induced Antihypertensive Action in Hypertensive Patients.
    Luchsinger A; Velasco M; Arbona E; Forte P; Gómez J; Sukerman M; Urbina A; Pieretti OH
    Am J Ther; 1995 Jun; 2(6):388-394. PubMed ID: 11850682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of diazoxide on severe pulmonary hypertension].
    Raimondi GA
    Medicina (B Aires); 1990; 50(3):198-204. PubMed ID: 2130205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease.
    Alvarez Kindelan A; Pérez Navero JL; Ibarra de la Rosa I; Concha Ruiz M; Montilla López P; Romanos Lezcano A
    Crit Care Med; 1994 Nov; 22(11):1754-61. PubMed ID: 7956278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.